1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study.
Level 5 - mechanism / opinion, no new human data
Animal autoradiographic study with no human data
PubMed 2828283 · doi:10.1007/BF00496810
What was done
Adult rats and mice on normal or vitamin D-deficient diets received injections of 3H 1,25 (OH)2 vitamin D3. Uptake was mapped across brain regions using autoradiography. Specificity was tested by pre-injecting excess unlabeled 1,25 (OH)2 vitamin D3 or excess 25 (OH) vitamin D3 prior to the labeled hormone.
What was found
The abstract reports no numerical values. Injected 3H 1,25 (OH)2 vitamin D3 concentrated in neuronal nuclei in specific brain regions. Nuclear labeling was prevented or decreased by competition with excess unlabeled 1,25 (OH)2 vitamin D3, but was not prevented by excess 25 (OH) vitamin D3. The highest nuclear concentrations were observed in the nucleus interstitialis striae terminalis and the central nucleus of the amygdala. Nuclear labeling was also identified in hypothalamic and preoptic nuclei (periventricular, parvocellular paraventricular, arcuate, and ventromedial nuclei), supramammillary nucleus, reticular nucleus of the thalamus, ventral hippocampus, caudate nucleus, pallium, midbrain-pontine central gray, dorsal raphe nucleus, parabrachial nuclei, cranial motor nuclei, sensory trigeminal substantia gelatinosa, and cerebellar Golgi type II cells.
Why it matters
This mapping demonstrates localized nuclear genomic target sites for active vitamin D3 in the mammalian central nervous system, identifying specific neural circuits through which the hormone may modulate neuroendocrine and behavioral functions.
Limits
The study was conducted entirely in rodent models, and the abstract does not report sample sizes, quantitative binding affinities, or functional physiological outcomes. Findings cannot be directly generalized to human brain localization without clinical or human tissue validation.
Cited by
- supports Walter Stumpf published scientific articles demonstrating that vitamin D receptors are present in the brainstem nucleus responsible for sleep motor paralysis and in circadian clock nuclei.